REQUEST A DEMO
Total
USD $0.00
Search more companies

Guizhou Yibai Pharmaceutical Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Guizhou Yibai Pharmaceutical Co.,Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is mainly engaged in the development, production and sale of modern Chinese medicine. Currently products are mainly divided into four categories: cough category, cardiovascular, anti-tumor and anti-viral. Its main products are Keke capsule, cough syrup in children, Eddie injection and so on. Among them, Keke capsule and Aidi injection of traditional Chinese medicine are two protected species, most of which make into the "national basic medical insurance and industrial injury insurance drug list".The company is a high-tech enterprises in Guizhou Province, where the treatment of cancer and cardiovascular class diseases of the drug was included in Guizhou Province. A major scientific and technological industrialization projects. Companies were in August 2000 and January 2004 by the State Food and Drug Administration GMP certification.

Headquarters
No. 220-1, Baiyun Avenue, Guiyang City, Guizhou Province
Guiyang; Guizhou; Postal Code: 550008

Contact Details: Purchase the Guizhou Yibai Pharmaceutical Co.,Ltd report to view the information.

Website: http://www.gzcci.com

Basic Information
Total Employees:
Purchase the Guizhou Yibai Pharmaceutical Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Guizhou Yibai Pharmaceutical Co.,Ltd report to view the information.
Registered Capital:
Purchase the Guizhou Yibai Pharmaceutical Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Guizhou Yibai Pharmaceutical Co.,Ltd report to view the information.
Incorporation Date:
June 12, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
23.42%
Purchase this report to view the information.
2.6%
Purchase this report to view the information.
1.1%
Purchase this report to view the information.
1.04%
Purchase this report to view the information.
1.01%
Subsidiaries
Beijing Yibai Pharmaceutical Research Co., Ltd.
Deyang Cancer Hospital Co., Ltd.
Guizhou Healthy Agriculture And Traditional Chinese Medicine Food Industry Development Group Co., Ltd.
Company Performance
Financial values in the chart are available after Guizhou Yibai Pharmaceutical Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-19.8%
Total operating revenue
-19.79%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-14.98%
Total equity
-17.15%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-4.71%
Quick Ratio
-0.25%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?